Urinary Catheters Coated with a Novel Biofilm Preventative Agent Inhibit Biofilm Development by Diverse Bacterial

Stephany Navarro1, Ethan Sherman2, Jane A Colmer-Hamood1,3

  • 1Department of Immunology and Molecular Microbiology, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.

Insights

A novel biofilm preventative agent (BPA) coating on silicone urinary catheters effectively inhibited biofilm formation by common UTI pathogens. However, Pseudomonas aeruginosa showed resistance, linked to its lipopolysaccharide composition.

Area of Science:

  • Medical Microbiology
  • Biomaterials Science
  • Infectious Disease Prevention

Background:

  • Catheter-associated urinary tract infections (CAUTIs) are prevalent healthcare-associated infections despite preventative guidelines.
  • Biofilm formation on urinary catheters is a primary cause of CAUTI, necessitating novel prevention strategies.
  • Previous research demonstrated an antimicrobial/antibiofilm agent's efficacy against Gram-positive and Gram-negative bacterial pathogens.

Purpose of the Study:

  • To evaluate a novel biofilm preventative agent (BPA) coating on silicone urinary catheters for inhibiting biofilm formation by key uropathogens.
  • To assess the efficacy of BPA-coated silicone catheters against common UTI-causing bacteria, including multidrug-resistant and Gram-positive strains.
  • To investigate the mechanism of resistance observed in Pseudomonas aeruginosa to the BPA coating.

Main Methods:

  • Six uropathogenic bacterial strains (three Escherichia coli, Enterobacter cloacae, Pseudomonas aeruginosa, methicillin-resistant Staphylococcus aureus) were used.
  • Biofilm formation on red rubber, PVC, and silicone catheters was assessed using a microtiter plate assay in artificial urine medium.
  • Silicone catheters were coated with BPA (benzalkonium chloride, polyacrylic acid, glutaraldehyde) and re-tested for biofilm inhibition, with specific lipopolysaccharide (LPS) mutants of P. aeruginosa used to explore resistance.

Main Results:

  • All tested uropathogens formed significant biofilms on uncoated red rubber, PVC, and silicone catheters.
  • BPA-coated silicone catheters completely prevented biofilm development by all tested uropathogens except P. aeruginosa.
  • P. aeruginosa exhibited resistance to the BPA coating, which was linked to its lipopolysaccharide (LPS) composition, as LPS mutants showed reduced biofilm formation on coated catheters.

Conclusions:

  • BPA-coated silicone urinary catheters demonstrate significant potential in preventing biofilm formation by a majority of common Gram-negative and Gram-positive uropathogens.
  • The LPS structure of P. aeruginosa confers resistance to the BPA coating, highlighting a specific challenge for this pathogen.
  • Further research into modifying BPA or catheter materials may be needed to overcome P. aeruginosa resistance and achieve comprehensive CAUTI prevention.

Related Concept Videos

Biofilms01:29

Biofilms

Biofilms are complex communities of microorganisms encased in a self-produced extracellular polysaccharide matrix attached to surfaces. These microbial consortia can include single or multiple species, providing enhanced survival benefits by forming organized, multilayered structures.The formation of biofilms occurs through four key stages: attachment, colonization, development, and dispersal.During attachment, free-swimming planktonic cells adhere to a surface, often facilitated by...
195
Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
29
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
24
Urinary Tract Infection IV: Nursing Management01:17

Urinary Tract Infection IV: Nursing Management

In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs...
70
Surface Membrane Barriers01:18

Surface Membrane Barriers

The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
1.3K